Susquehanna International Group
COCH icon

Susquehanna International Group’s Envoy Medical COCH Stock Holding History

Susquehanna International Group’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.5K Sell
35,297
-83,818
-70% -$57.1K ﹤0.01% 12826
2025
Q4 		$78.7K Buy
+119,115
New +$94.3K ﹤0.01% 11574
2023
Q1 		– Sell
-61,474
Closed -$621K – 12655
2022
Q4 		$621K Hold
61,474
– – ﹤0.01% 7308
2022
Q3 		$604K Buy
+61,474
New +$604K ﹤0.01% 7976

Other funds holding COCH

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCA
DSG Capital Advisors Edina, Minnesota $625M AUM 30.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM

Susquehanna International Group's COCH Position: Q1 2026 in Review

Susquehanna International Group reduced its Envoy Medical (COCH) stake by 70% in Q1 2026, selling an estimated $57.1K and leaving 35,297 shares worth $23.5K. The position accounts for ﹤0.01% of the portfolio, ranked #12826.

Susquehanna International Group first reported a position in COCH in Q3 2022 and has held it in 4 quarters since. The position peaked at $621K in Q4 2022. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • Susquehanna International Group held 35,297 shares of Envoy Medical worth $23.5K as of Q1 2026.
  • Susquehanna International Group sold 83,818 Envoy Medical shares in Q1 2026, an estimated $57.1K.
  • Envoy Medical made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12826 holding.
  • Susquehanna International Group first reported a position in Envoy Medical in Q3 2022 and has held it in 4 quarters since.
  • Susquehanna International Group's Envoy Medical position peaked at $621K in Q4 2022.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.